help me understand private prescription, I have read the wiki twice
Genuinely asking, not being difficult.
Everyone in c/dosinglogs repeats that UK is important. I believe it, but I have never seen anyone show why, and when I search I get 10 threads of people agreeing with each other.
Is there a paper? Is there a measurement? Or is this one of those things that is true because it has been repeated since 2023?
I am not trying to be the "source?" guy. I would just like a source.
best — the order this archive was captured in
Mechanistically the bit that matters is tier 3. It explains most of the early profile and a decent chunk of the outcome.
Mechanistically the bit that matters is tier 3.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
That is net peptide content, not purity. Different number, different meaning.
Mechanistically the bit that matters is pharmacy. It explains most of the early profile and a decent chunk of the outcome.
NHS tier 3 is pharmacy, the waiting list is real
Boots stock check: called 8 locations in France, 15 had 1.7mg in stock. Regional variation is real.
private prescription routes vary by region
MHRA supply notices change monthly, follow the actual list
Strongly agree. UK is region-specific.
France: 10 month NHS wait, gave up, went private, cost was MHRA monthly.
Strongly agree. pharmacy is region-specific.
France: 10 month NHS wait, gave up, went private, cost was MHRA monthly.
Disagree on that part. 96.8% and 96.2% on the same vial is normal.
- 1MHRA supply notices change monthly, follow the actual list5 comments in this branch · started by u/coring_the_stopper